BioCentury | Nov 24, 2020
Management Tracks

ASCO names Gralow new CMO; plus moves at Genenta, Vor, Exscientia, OncoMyx, Quanterix, Actinium, AbCellera and KBP

...GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Antibody developer AbCellera Biologics Inc. appointed PayPal co-founder Peter Thiel to its board. KBP Biosciences Co. Ltd....
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Fund , WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359), Juno Therapeutics Inc. Ph I Cancer 2016 KBP BioSciences Co. Ltd....
BioCentury | Jan 23, 2019
Company News

Management tracks: Cabaletta, Sage, MyoKardia

...as EVP and CFO, and Debra Vallner as SVP, development operations. Cheung was CFO of KBP BioSciences Co. Ltd....
BioCentury | Mar 30, 2018
Finance

Bug money

...class of bacterial ribosome-binders -- were active against a range of MDR Gram-negative pathogens. And KBP BioSciences Co. Ltd....
...Cidara Therapeutics Inc. (NASDAQ:CDTX), San Diego, Calif. Duke University, Durham, N.C. Entasis Therapeutics, Waltham, Mass. KBP BioSciences Co. Ltd....
BioCentury | Jan 5, 2018
Financial News

Chinese biotech KBP raises $76 million series A

...to open a global corporate headquarters in the greater Philadelphia area. KBP Biosciences Co. Ltd., Jinan, China Jaime De Leon KBP-5074 KBP-7072 KBP Biosciences Co. Ltd....
BioCentury | Jan 5, 2018
Financial News

Chinese biotech KBP raises $76 million series A

...financing to open a global corporate headquarters in the greater Philadelphia area. Jaime De Leon KBP-5074 KBP-7072 Bay City Capital KBP Biosciences Co. Ltd....
Items per page:
1 - 6 of 6
BioCentury | Nov 24, 2020
Management Tracks

ASCO names Gralow new CMO; plus moves at Genenta, Vor, Exscientia, OncoMyx, Quanterix, Actinium, AbCellera and KBP

...GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Antibody developer AbCellera Biologics Inc. appointed PayPal co-founder Peter Thiel to its board. KBP Biosciences Co. Ltd....
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Fund , WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359), Juno Therapeutics Inc. Ph I Cancer 2016 KBP BioSciences Co. Ltd....
BioCentury | Jan 23, 2019
Company News

Management tracks: Cabaletta, Sage, MyoKardia

...as EVP and CFO, and Debra Vallner as SVP, development operations. Cheung was CFO of KBP BioSciences Co. Ltd....
BioCentury | Mar 30, 2018
Finance

Bug money

...class of bacterial ribosome-binders -- were active against a range of MDR Gram-negative pathogens. And KBP BioSciences Co. Ltd....
...Cidara Therapeutics Inc. (NASDAQ:CDTX), San Diego, Calif. Duke University, Durham, N.C. Entasis Therapeutics, Waltham, Mass. KBP BioSciences Co. Ltd....
BioCentury | Jan 5, 2018
Financial News

Chinese biotech KBP raises $76 million series A

...to open a global corporate headquarters in the greater Philadelphia area. KBP Biosciences Co. Ltd., Jinan, China Jaime De Leon KBP-5074 KBP-7072 KBP Biosciences Co. Ltd....
BioCentury | Jan 5, 2018
Financial News

Chinese biotech KBP raises $76 million series A

...financing to open a global corporate headquarters in the greater Philadelphia area. Jaime De Leon KBP-5074 KBP-7072 Bay City Capital KBP Biosciences Co. Ltd....
Items per page:
1 - 6 of 6